Molecular characteristics in papillary thyroid cancers (PTCs) with no131I uptake-Reference-Cited by-同舟云学术

Molecular characteristics in papillary thyroid cancers (PTCs) with no131I uptake

Published:2008-01 Issue:1 Volume:68 Page:108-116
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Mian Caterina,Barollo Susi,Pennelli Gianmaria,Pavan Nicodemo,Rugge Massimo,Pelizzo Maria Rosa,Mazzarotto Renzo,Casara Dario,Nacamulli Davide,Mantero Franco,Opocher Giuseppe,Busnardo Benedetto,Girelli Maria Elisa

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2007.03008.x/fullpdf

Reference35 articles.

1. Cloning and characterization of the thyroid iodide transporter;Dai;Nature,1996

2. Thyroid Na+/I− symporter: mechanism, stoichiometry, and specificity;Eskandari;Journal of Biological Chemistry,1997

3. Pendrin, the protein encoded by the Pendred's syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells;Royaux;Endocrinology,2000

4. Expression of pendrin and Pendred syndrome (PDS) gene in human thyroid tissues;Bidart;Journal of Clinical Endocrinology and Metabolism,2000

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer;Chinese Journal of Cancer Research;2024

2. Relationship of Recurrence Rate with some Characteristics in Patients with Thyroid Carcinoma;Indian Journal of Endocrinology and Metabolism;2023-11

3. Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review;Reviews in Endocrine and Metabolic Disorders;2023-10-24

4. Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers;Frontiers in Endocrinology;2023-06-08

5. Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy;Drug Resistance Updates;2023-05